Barinthus Biotherapeutics plc (BRNS)

NASDAQ: BRNS · Real-Time Price · USD

1.330

+0.030 (2.31%)

At close: Oct 29, 2025, 4:00 PM EDT

1.400

+0.070 (5.26%)

After-hours: Oct 29, 2025, 7:42 PM EDT

Revenue by Product

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
Immunotherapies and Vaccines	14.97M	Log In	Log In	Log In	Log In	Upgrade
Immunotherapies and Vaccines Growth	1766.46%	Log In	Log In	Log In	Log In	Upgrade

Revenue by Geography

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	2017 - 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	2017 - 2019
United Kingdom	14.97M	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States	-	Log In	Log In	Log In	Log In	Upgrade
United Kingdom and United States Growth	-	Log In	Log In	Log In	Log In	Upgrade